Patents Assigned to Curovir AB
  • Patent number: 12319696
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof, wherein one of X and Y is O and the other one is N; R1 is selected from halogen, CN, NH(CH3), N(CH3)2, C1-C4 alkoxy wherein the alkyl moiety of the C1-C4 alkoxy is optionally substituted by 1-3 halogens, and C1-C4 alkyl, wherein the C1-C4 alkyl is optionally substituted by 1-3 halogens, CN, NH(CH3), or N(CH3)2; and R2 is 3,4-dimethoxyphenyl or 1,3-dimethyl-1H-indazol-5-yl.
    Type: Grant
    Filed: August 20, 2019
    Date of Patent: June 3, 2025
    Assignee: CUROVIR AB
    Inventor: Jacob Westman
  • Patent number: 11001587
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof, useful in therapy, in particular in the treatment of a viral infection or a disease linked to impaired or abnormal autophagy.
    Type: Grant
    Filed: April 4, 2018
    Date of Patent: May 11, 2021
    Assignee: CUROVIR AB
    Inventor: Jacob Westman
  • Patent number: 10407429
    Abstract: A compound of formula (I), or a pharmaceutically acceptable salt thereof, useful in therapy, in particular in the treatment of a viral infection.
    Type: Grant
    Filed: June 10, 2016
    Date of Patent: September 10, 2019
    Assignee: Curovir AB
    Inventor: Jacob Westman
  • Publication number: 20180298007
    Abstract: A compound of formula (I), or a pharmaceutically acceptable salt thereof, useful in therapy, in particular in the treatment of a viral infection.
    Type: Application
    Filed: June 10, 2016
    Publication date: October 18, 2018
    Applicant: Curovir AB
    Inventor: Jacob WESTMAN
  • Patent number: 9963455
    Abstract: A compound of formula (I) or a pharmaceutically acceptable salt thereof, useful in therapy, in particular in the treatment of a viral infection.
    Type: Grant
    Filed: January 21, 2015
    Date of Patent: May 8, 2018
    Assignee: Curovir AB
    Inventor: Jacob Westman